Joanne Weidhaas, MD
Enriched profileProfessor and Vice Chair, Division of Molecular and Cellular Oncology, Department of Radiation Oncology · UCLA Health
Joanne Weidhaas is Professor and Vice Chair, Division of Molecular and Cellular Oncology, Department of Radiation Oncology at UCLA Health. ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 17 Nov 2026
Joanne B. Weidhaas, MD, is Professor and Vice Chair, Division of Molecular and Cellular Oncology, Department of Radiation Oncology at UCLA Health. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 1 companies, 3 NIH-funded awards (2007–2014).
- Top research focus: Breast Cancer
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Sponsor: Jonsson Comprehensive Cancer Center
- Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
Sponsor: Yale University
Industry payments
Updated 13 Nov 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
NIH funding
Updated 13 Nov 2026
3 NIH research awards on record, funded 2007–2014 per NIH RePORTER. The latest:
- Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
University of California Los Angeles
FY2023$364,015R01CA238998 - Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
University of California Los Angeles
FY2022$364,012R01CA238998 - Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
University of California Los Angeles
FY2021$371,444R01CA238998
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 13 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/joanne-weidhaas-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
profiles.ucla.edu/joanne.weidhaas
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucla.edu ↗ - Other
uclahealth.org/cancer/members/joanne-weidhaas
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclahealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Secondary affiliations
appointments beyond the home institution- Co-founder
MiraDX (molecular diagnostics company), per UCLA profile
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclahealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lin Chang, MD
UCLA Health
Priscilla Hsue, MD
UCLA Health
Helen Lavretsky, MD
UCLA Health
Sahib Khalsa, MD
UCLA Health
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Norman Wolmark, MD
University of Pittsburgh
Hope Rugo, MD
City of Hope